Skip to main content
Clinical Trials/NCT00115102
NCT00115102CompletedPhase 4

Sensory Examination and Pharmacological Modulation of Oral Hyperexcitability in Patients With Atypical Odontalgia and Matched Healthy Controls

University of Aarhus1 site in 1 country20 target enrollmentStarted: March 1, 2004Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
20
Locations
1
Primary Endpoint
Pain

Study Overview

Brief Summary

This project examines experimental pain and chronic pain in the mouth, specifically the condition called atypical odontalgia (AO:atypical toothpain). In 16 patients with AO and 16 healthy persons, capsaicin (chili-pepper) is applied to the gingiva to cause pain. This pain is evaluated by the participants. In three sessions, 3 different medications are tested for effect on the pain. The medications are fentanyl, S-ketamine and placebo-treatment (saline). The aim is to know more about pain mechanisms in AO in order to develop an effective treatment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Diagnostic
Masking
Double

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Atypical odontalgia

Exclusion Criteria

  • •BMI > 30
  • •Heart conditions
  • •Lung disease
  • •Diseases of the liver or kidneys
  • •Hypertension, untreated

Outcomes

Primary Outcomes

Pain

Sensitivity to heat and cold

Sensitivity to mechanical stimuli

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials